Back to Search
Test Name REF LAB SOLID TUMOR CORE PANEL
Orderable CPT -
OVT 123002562
Synonyms -
Result Test Name QUEST VARIANT FREQUENCY 6
Laboratory QUEST LAB
Result Test Code 12386010218
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 1
Laboratory QUEST LAB
Result Test Code 12386010186
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 3
Laboratory QUEST LAB
Result Test Code 12386010195
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 1
Laboratory QUEST LAB
Result Test Code 12386030217
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 2
Laboratory QUEST LAB
Result Test Code 12386030219
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 7
Laboratory QUEST LAB
Result Test Code 12386030214
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 50398-7
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 8
Laboratory QUEST LAB
Result Test Code 12386030216
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 11
Laboratory QUEST LAB
Result Test Code 12386030273
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 12
Laboratory QUEST LAB
Result Test Code 12386030284
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST REVIEWER
Laboratory QUEST LAB
Result Test Code 12386030287
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 11
Laboratory QUEST LAB
Result Test Code 12386030273
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE REGIONS FAILING QC
Laboratory QUEST LAB
Result Test Code 12386030285
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 8
Laboratory QUEST LAB
Result Test Code 12386010280
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST SPECIMEN TYPE
Laboratory QUEST LAB
Result Test Code 12386030200
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 4
Laboratory QUEST LAB
Result Test Code 12386010203
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 5
Laboratory QUEST LAB
Result Test Code 12386010266
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 2
Laboratory QUEST LAB
Result Test Code 12386010187
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 2
Laboratory QUEST LAB
Result Test Code 12386010189
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 11
Laboratory QUEST LAB
Result Test Code 12386030251
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 12
Laboratory QUEST LAB
Result Test Code 12386030260
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 11
Laboratory QUEST LAB
Result Test Code 12386030278
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 7
Laboratory QUEST LAB
Result Test Code 12386030230
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 9
Laboratory QUEST LAB
Result Test Code 12386030235
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 9
Laboratory QUEST LAB
Result Test Code 12386030239
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 10
Laboratory QUEST LAB
Result Test Code 12386030244
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 3
Laboratory QUEST LAB
Result Test Code 12386030205
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 5
Laboratory QUEST LAB
Result Test Code 12386010263
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 8
Laboratory QUEST LAB
Result Test Code 12386010281
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 4
Laboratory QUEST LAB
Result Test Code 12386030207
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 3
Laboratory QUEST LAB
Result Test Code 12386010194
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 3
Laboratory QUEST LAB
Result Test Code 12386010197
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 5
Laboratory QUEST LAB
Result Test Code 12386010208
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 4
Laboratory QUEST LAB
Result Test Code 12386010260
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 11
Laboratory QUEST LAB
Result Test Code 12386030248
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 9
Laboratory QUEST LAB
Result Test Code 12386030264
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 10
Laboratory QUEST LAB
Result Test Code 12386030271
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 6
Laboratory QUEST LAB
Result Test Code 12386010268
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 6
Laboratory QUEST LAB
Result Test Code 12386010271
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 10
Laboratory QUEST LAB
Result Test Code 12386030241
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 8
Laboratory QUEST LAB
Result Test Code 12386030215
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 8
Laboratory QUEST LAB
Result Test Code 12386030231
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 4
Laboratory QUEST LAB
Result Test Code 12386010261
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 6
Laboratory QUEST LAB
Result Test Code 12386010267
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 4
Laboratory QUEST LAB
Result Test Code 12386010257
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST INTERACTING VARIANTS
Laboratory QUEST LAB
Result Test Code 12386010237
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST PUBLICATION
Laboratory QUEST LAB
Result Test Code 12386010239
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 1
Laboratory QUEST LAB
Result Test Code 12386010243
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 2
Laboratory QUEST LAB
Result Test Code 12386010248
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 6
Laboratory QUEST LAB
Result Test Code 12386010221
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 35526-3
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 2
Laboratory QUEST LAB
Result Test Code 12386030203
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 1
Laboratory QUEST LAB
Result Test Code 12386010245
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 7
Laboratory QUEST LAB
Result Test Code 12386010273
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE REGIONS PASSING QC
Laboratory QUEST LAB
Result Test Code 12386010241
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 9
Laboratory QUEST LAB
Result Test Code 12386030263
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 9
Laboratory QUEST LAB
Result Test Code 12386030266
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALWAYS STATEMENT
Laboratory QUEST LAB
Result Test Code 12386010240
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 10
Laboratory QUEST LAB
Result Test Code 12386030246
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 12
Laboratory QUEST LAB
Result Test Code 12386030259
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 7
Laboratory QUEST LAB
Result Test Code 12386010228
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 6
Laboratory QUEST LAB
Result Test Code 12386010216
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 7
Laboratory QUEST LAB
Result Test Code 12386010225
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 29308-4
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 10
Laboratory QUEST LAB
Result Test Code 12386030243
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 9
Laboratory QUEST LAB
Result Test Code 12386030234
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 9
Laboratory QUEST LAB
Result Test Code 12386030236
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 9
Laboratory QUEST LAB
Result Test Code 12386030238
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 1
Laboratory QUEST LAB
Result Test Code 12386010183
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 2
Laboratory QUEST LAB
Result Test Code 12386010190
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 5
Laboratory QUEST LAB
Result Test Code 12386010211
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 5
Laboratory QUEST LAB
Result Test Code 12386010214
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 1
Laboratory QUEST LAB
Result Test Code 12386010181
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 4
Laboratory QUEST LAB
Result Test Code 12386010207
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 6
Laboratory QUEST LAB
Result Test Code 12386010215
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 3
Laboratory QUEST LAB
Result Test Code 12386010196
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 4
Laboratory QUEST LAB
Result Test Code 12386010201
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 8
Laboratory QUEST LAB
Result Test Code 12386030232
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 8
Laboratory QUEST LAB
Result Test Code 12386010278
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 6
Laboratory QUEST LAB
Result Test Code 12386030211
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 1
Laboratory QUEST LAB
Result Test Code 12386030218
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 10
Laboratory QUEST LAB
Result Test Code 12386030242
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 12
Laboratory QUEST LAB
Result Test Code 12386030257
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 9
Laboratory QUEST LAB
Result Test Code 12386030262
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 11
Laboratory QUEST LAB
Result Test Code 12386030275
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 12
Laboratory QUEST LAB
Result Test Code 12386030279
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 7
Laboratory QUEST LAB
Result Test Code 12386030213
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 4
Laboratory QUEST LAB
Result Test Code 12386030223
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 5
Laboratory QUEST LAB
Result Test Code 12386030225
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 6
Laboratory QUEST LAB
Result Test Code 12386030228
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 9
Laboratory QUEST LAB
Result Test Code 12386030233
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 2
Laboratory QUEST LAB
Result Test Code 12386010188
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 2
Laboratory QUEST LAB
Result Test Code 12386010193
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 2
Laboratory QUEST LAB
Result Test Code 12386010247
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 4
Laboratory QUEST LAB
Result Test Code 12386010258
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 7
Laboratory QUEST LAB
Result Test Code 12386010276
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST BLOCK ID
Laboratory QUEST LAB
Result Test Code 12386007476
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 21702-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST DIAGNOSIS:
Laboratory QUEST LAB
Result Test Code 12385997341
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 21719-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 1
Laboratory QUEST LAB
Result Test Code 12386010246
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 8
Laboratory QUEST LAB
Result Test Code 12386010231
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 8
Laboratory QUEST LAB
Result Test Code 12386010230
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 1
Laboratory QUEST LAB
Result Test Code 12386010242
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 12
Laboratory QUEST LAB
Result Test Code 12386030282
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 12
Laboratory QUEST LAB
Result Test Code 12386030258
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 11
Laboratory QUEST LAB
Result Test Code 12386030274
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 11
Laboratory QUEST LAB
Result Test Code 12386030277
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 12
Laboratory QUEST LAB
Result Test Code 12386030254
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 8
Laboratory QUEST LAB
Result Test Code 12386010229
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 1
Laboratory QUEST LAB
Result Test Code 12386010182
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 4
Laboratory QUEST LAB
Result Test Code 12386010204
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 11
Laboratory QUEST LAB
Result Test Code 12386030249
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 4
Laboratory QUEST LAB
Result Test Code 12386030224
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 5
Laboratory QUEST LAB
Result Test Code 12386030226
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 11
Laboratory QUEST LAB
Result Test Code 12386030247
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 5
Laboratory QUEST LAB
Result Test Code 12386030209
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 3
Laboratory QUEST LAB
Result Test Code 12386010252
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 3
Laboratory QUEST LAB
Result Test Code 12386010255
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 5
Laboratory QUEST LAB
Result Test Code 12386010262
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST OVERALL INTERPRETATION
Laboratory QUEST LAB
Result Test Code 12386017676
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 5
Laboratory QUEST LAB
Result Test Code 12386010265
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 8
Laboratory QUEST LAB
Result Test Code 12386010277
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 2
Laboratory QUEST LAB
Result Test Code 12386010250
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENES NEGATIVE FOR VARIANTS
Laboratory QUEST LAB
Result Test Code 12386030286
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 10
Laboratory QUEST LAB
Result Test Code 12386030269
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 11
Laboratory QUEST LAB
Result Test Code 12386030276
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 11
Laboratory QUEST LAB
Result Test Code 12386030250
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 10
Laboratory QUEST LAB
Result Test Code 12386030268
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 4
Laboratory QUEST LAB
Result Test Code 12386030208
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 2
Laboratory QUEST LAB
Result Test Code 12386030220
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 12
Laboratory QUEST LAB
Result Test Code 12386030281
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 1
Laboratory QUEST LAB
Result Test Code 12386030201
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 1
Laboratory QUEST LAB
Result Test Code 12386030202
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 10
Laboratory QUEST LAB
Result Test Code 12386030272
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 10
Laboratory QUEST LAB
Result Test Code 12386030272
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 12
Laboratory QUEST LAB
Result Test Code 12386030280
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 12
Laboratory QUEST LAB
Result Test Code 12386030283
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 10
Laboratory QUEST LAB
Result Test Code 12386030270
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 3
Laboratory QUEST LAB
Result Test Code 12386030222
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 6
Laboratory QUEST LAB
Result Test Code 12386010270
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 7
Laboratory QUEST LAB
Result Test Code 12386010275
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 3
Laboratory QUEST LAB
Result Test Code 12386030221
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 7
Laboratory QUEST LAB
Result Test Code 12386010224
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 8
Laboratory QUEST LAB
Result Test Code 12386010235
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ADDITIONAL VARIANTS
Laboratory QUEST LAB
Result Test Code 12386010238
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 2
Laboratory QUEST LAB
Result Test Code 12386010251
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 1
Laboratory QUEST LAB
Result Test Code 12386010180
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 3
Laboratory QUEST LAB
Result Test Code 12386010200
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 5
Laboratory QUEST LAB
Result Test Code 12386010209
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 7
Laboratory QUEST LAB
Result Test Code 12386010222
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 8251-1
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 7
Laboratory QUEST LAB
Result Test Code 12386010223
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 12
Laboratory QUEST LAB
Result Test Code 12386030256
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 9
Laboratory QUEST LAB
Result Test Code 12386030265
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 11
Laboratory QUEST LAB
Result Test Code 12386030253
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 12
Laboratory QUEST LAB
Result Test Code 12386030255
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 3
Laboratory QUEST LAB
Result Test Code 12386010253
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 3
Laboratory QUEST LAB
Result Test Code 12386010256
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 7
Laboratory QUEST LAB
Result Test Code 12386010272
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST SOURCE
Laboratory QUEST LAB
Result Test Code 12386016054
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 11
Laboratory QUEST LAB
Result Test Code 12386030252
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 6
Laboratory QUEST LAB
Result Test Code 12386010217
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 8
Laboratory QUEST LAB
Result Test Code 12386010232
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 6
Laboratory QUEST LAB
Result Test Code 12386030227
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 10
Laboratory QUEST LAB
Result Test Code 12386030240
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 10
Laboratory QUEST LAB
Result Test Code 12386030245
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 4
Laboratory QUEST LAB
Result Test Code 12386010202
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 5
Laboratory QUEST LAB
Result Test Code 12386010210
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 9
Laboratory QUEST LAB
Result Test Code 12386030237
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 9
Laboratory QUEST LAB
Result Test Code 12386030261
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 10
Laboratory QUEST LAB
Result Test Code 12386030267
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 7
Laboratory QUEST LAB
Result Test Code 12386030229
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 3
Laboratory QUEST LAB
Result Test Code 12386030206
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 5
Laboratory QUEST LAB
Result Test Code 12386030210
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 6
Laboratory QUEST LAB
Result Test Code 12386030212
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC 69426-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 2
Laboratory QUEST LAB
Result Test Code 12386030204
Laboratory Test Name QUEST SOLID TUMOR CORE PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Core Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and anal*
Shipping Instructions Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements